Publications

2013

Lipski AC, Lakotka N, Riechardt AI, Willerding GD, Heufelder J, Türkmen S, Keilholz U, Moser L, Joussen AM.
[Diagnosis of and Therapy for Choroidal Melanoma.]
Klin Monbl Augenheilkd. 2013 Sep 17.

Baumunk D, Reunkoff R, Kushner J, Baumunk A, Kempkensteffen C, Steiner U, Weikert S, Moser L, Schrader M, Höcht S, Wiegel T, Miller K, Schostak M.
Interdisciplinary decision making in prostate cancer therapy - 5-years' time trends at the Interdisciplinary Prostate Cancer Center (IPC) of the Charité Berlin.
BMC Med Inform Decis Mak. 2013 Aug 5;13:83.

Elezkurtaj S, Moser L, Budczies J, Müller AJ, Bläker H, Buhr HJ, Dietel M, Kruschewski M.
Histopathological regression grading matches excellently with local and regional spread after neoadjuvant therapy of rectal cancer.
Pathol Res Pract. 2013 Jul;209(7):424-8.

Wirth A, Gospodarowicz M, Aleman BM, Bressel M, Ng A, Chao M, Hoppe RT, Thieblemont C, Tsang R, Moser L, Specht L, Szpytma T, Lennard A, Seymour JF, Zucca E.
Long-term outcome for gastric marginal zone lymphoma treated with radiotherapy: a retrospective, multi-centre, International Extranodal Lymphoma Study Group study.
Ann Oncol. 2013 May;24(5):1344-51.

Burmeister T, Molkentin M, Meyer C, Lachmann N, Schwartz S, Friedrichs B, Beyer J, Blau IW, Lohm G, Tietze-Bürger C, Marschalek R, Uharek L.
Molecular monitoring of minimal residual disease in two patients with MLL-rearranged acute myeloid leukemia and haploidentical transplantation after relapse.
Exp Hematol Oncol. 2012 Apr 18;1(1):6.

Lohm G, Bottke D, Jamil B, Miller K, Neumann K, Bartkowiak D, Hinkelbein W, Wiegel T.
Salvage radiotherapy in patients with persistently detectable PSA or PSA rising from an undetectable range after radical prostatectomy gives comparable results.
World J Urol. 2013 Apr;31(2):423-8.

Bottke D, Golz R, Störkel S, Hinke A, Siegmann A, Hertle L, Miller K, Hinkelbein W, Wiegel T.
Phase 3 study of adjuvant radiotherapy versus wait and see in pT3 prostate cancer: impact of pathology review on analysis.
Eur Urol. 2013 Aug;64(2):193-8.

Helbling D, Bodoky G, Gautschi O, Sun H, Bosman F, Gloor B, Burkhard R, Winterhalder R, Madlung A, Rauch D, Saletti P, Widmer L, Borner M, Baertschi D, Yan P, Benhattar J, Leibundgut EO, Bougel S, Koeberle D.
Neoadjuvant chemoradiotherapy with or without panitumumab in patients with wild-type KRAS, locally advanced rectal cancer (LARC): a randomized, multicenter, phase II trial SAKK 41/07.
Ann Oncol. 2013 Mar;24(3):718-25.

To top

2012

Lohm G, Bottke D, Jamil B, Miller K, Neumann K, Bartkowiak D, Hinkelbein W, Wiegel T.
Salvage radiotherapy in patients with persistently detectable PSA or PSA rising from an undetectable range after radical prostatectomy gives comparable results.
World J Urol. 2012 Mar 30

Winzer KJ, Gruber C, Badakhshi H, Hinkelbein M, Denkert C.
Compliance of patients concerning recommended radiotherapy in breast cancer : Association with recurrence, age, and hormonal therapy.
Strahlenther Onkol. 2012 Sep;188(9):788-94.

Briganti A, Wiegel T, Joniau S, Cozzarini C, Bianchi M, Sun M, Tombal B, Haustermans K, Budiharto T, Hinkelbein W, Di Muzio N, Karakiewicz PI, Montorsi F, Van Poppel H.
Early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysis.
Eur Urol. 2012 Sep;62(3):472-87.

Kruschewski M, Ciurea M, Lipka S, Daum S, Moser L, Meyer B, Groene J, Budczies J, Buhr HJ.
Locally recurrent colorectal cacer: results of surgical therapy
Langenbecks Arch Surg 2012;397:1059-1067

To top

2011

Siegmann A, Bottke D, Faehndrich J, Lohm G, Miller K, Bartkowiak D, Wiegel T, Hinkelbein W.
Dose escalation for patients with decreasing PSA during radiotherapy for elevated PSA after radical prostatectomy improves biochemical progression-free survival: results of a retrospective study.
Strahlenther Onkol. 2011 Aug;187(8):467-72.

Siegmann A, Bottke D, Faehndrich J, Brachert M, Lohm G, Miller K, Bartkowiak D, Hinkelbein W, Wiegel T.
Salvage radiotherapy after prostatectomy - what is the best time to treat?
Radiother Oncol. 2012 May;103(2):239-43.

To top

2010

Moser L, Schmittel A.
Tumoren des HNO-Bereichs
in: Therapiealgorithmen Onkologie, Al-Batran SE, Hofheinz RD. rs Media GmbH Verlag 2010, ISBN: 978-3-00-032813-8.

Martin T, Wenz F, Boehmer D, Sedlmayr F, Hinkelbein W, Henkel TO, Miller K, Wiegel T.
Radiation therapy for prostate cancer in the new S3 guideline. Part 2: postoperative radiation therapy and brachytherapy.
Urologe 2010;49:216-220

Bechrakis NE, Schmid E, Blatsios G, Widmann-Schuchter B, Hoecht S, Moser L, Cordini D, Heufelder J, Willerding G, Foerster MH.
Rrotonenstrahlentherapie bei Aderhautmelanomen des hinteren Augenpolsr.
Spektrum Augenheilkd 2010;24:11-16

Boehmer D, Wenz F, Martin T, Sedlmayr F, Hinkelbein W, Wiegel T.
Radiation therapy for prostate cancer in the new S3 guideline. Part 1: localized and locally advanced prostate cancer.
Urologe 2010;49:211-215


Hoecht S, Heide J, Bischoff R, Grundel O, Carstens D.
Postoperative irradiation in non-small lung cancer.
Front Radiat Ther Oncol. 2010;42:145-149

To top

2009

Krause L, Mladenova A, Bechrakis NE, Kreusel K-M, Plath T, Moser L, Foerster M.
Treatment modalities for conjunctival melanoma.
Klin Monatsbl Augenh. 2009;226:1012-1016

Otto S, Lee L, Buhr HJ, Frericks B, Hoecht S, Kroesen AJ.
Staging anal cancer: prospective comparison of transanal endoscopic ultrasound and magnetic resonance imaging.
J Gastrointest Surg. 2009;135:1292-1298

Wiegel T, Bottke D, Steiner U, Siegmann A, Golz R, Störkel S, Willich N, Semjonow A, Souchon R, Stöckle M, Rübe C, Weissbach L, Althaus P, Rebmann U, Kälble T, Feldmann HJ, Wirth M, Hinke A, Hinkelbein W, Miller K.
Phase III Postoperative Adjuvant Radiotherapy After Radical Prostatectomy Compared With Radical Prostatectomy Alone in pT3 Prostate Cancer With Postoperative Undetectable Prostate-Specific Antigen: ARO 96-02/AUO AP 09/95.
J Clin Oncol. 2009;27(18):2924-2930

Wiegel T, Lohm G, Bottke D, Hoecht S, Miller K, Siegmann A, Schostak M, Neumann K, Hinkelbein W.
Achieving an Undetectable PSA After Radiotherapy for Biochemical Progression After Radical Prostatectomy Is an Independent Predictor of Biochemical Outcome - Results of a Retrospective Study
Int J Radiat Oncol Biol Phys. 2009 March 73(4):1009-1016.

To top

2008

Krause L, Ritter C, Wachtlin J, Kreusel K-M, Höcht S, Foerster MH, Bechrakis NE
Recurrence rate following adjuvant strontium-90 brachytherapy after excision of conjunctival melanoma.
Klinische Monatsblätter für Augenheilkunde 2008;225:649-652

Höcht S, Lohm G, Moser L, Hinkelbein W.
Radiotherapy in biochemical recurrences after surgery for prostate cancer.
Front Radiat Ther Oncol. 2008;41:77-85.

Moser L, Schubert T, Hinkelbein W.
Hormone-refractory and metastatic prostate cancer - palliative radiotherapy.
Front Radiat Ther Oncol. 2008;41:117-25.

Bottke D, Koychev D, Busse A, Heufelder K, Wiegel T, Thiel E, Hinkelbein W, Keilholz U.
Fractionated irradiation can induce functionally relevant multidrug resistance gene and protein expression in human tumor cell lines.
Radiat Res. 2008 Jul;170(1):41-8.

Moser L, Ritz JP, Hinkelbein W, Höcht S.
Adjuvant and neoadjuvant chemoradiation or radiotherapy in rectal cancer-a review focusing on open questions.
Int J Colorectal Dis. 2008 Mar;23(3):227-36.

To top

2007

Kiewe P, Dallenbach FE, Fischer L, Hoecht S, Kombos T, Thiel E, Korfel A.
Isolated B-cell lymphoproliferative disorder at the dura mater with B-cell chronic lymphocytic leukemia immunophenotype.
Clin Lymphoma Myeloma. 2007 Nov;7(9):594-6.

Deiner C, Loddenkemper C, Rauch U, Rosenthal P, Pauschinger M, Schwimmbeck PL, Schultheiss HP, Pels K.
Mechanisms of late lumen loss after antiproliferative percutaneous coronary intervention using beta-irradiation in a porcine model of restenosis.
Cardiovasc Revasc Med. 2007 Apr-Jun;8(2):94-8.

Deiner C, Shagdarsuren E, Schwimmbeck PL, Rosenthal P, Loddenkemper C, Rauch U, Pauschinger M, Dietz R, Schultheiss HP, Dechend R, Pels K.
Nf-kappab and AP-1 activation is associated with late lumen loss after porcine coronary angioplasty and antiproliferative beta-irradiation.
Cardiovasc Res. 2007 Jul 1;75(1):195-204.

Kreusel KM, Bechrakis NE, Krause L, Wiegel T, Foerster MH.
Incidence and clinical characteristics of symptomatic choroidal metastasis from breast cancer.
Acta Ophthalmol Scand. 2007 May;85(3):298-302.

Goldin-Lang P, Niebergall F, Antoniak S, Szotowski B, Rosenthal P, Pels K, Schultheiss HP, Rauch U.
Ionizing radiation induces upregulation of cellular procoagulability and tissue factor expression in human peripheral blood mononuclear cells.
Thromb Res. 2007;120(6):857-64.

Bottke D, Bathe K, Wiegel T, Hinkelbein W.
Phase I trial of radiochemotherapy with bendamustine in patients with recurrent squamous cell carcinoma of the head and neck.
Strahlenther Onkol. 2007 Mar;183(3):128-32.

Szotowski B, Antoniak S, Goldin-Lang P, Tran QV, Pels K, Rosenthal P, Bogdanov VY, Borchert HH, Schultheiss HP, Rauch U.
Antioxidative treatment inhibits the release of thrombogenic tissue factor from irradiation- and cytokine-induced endothelial cells.
Cardiovasc Res. 2007 Mar 1;73(4):806-12.

To top

2006

Hoecht S, Hinkelbein W.
Treatment of rectal cancer.
N Engl J Med. 2006 Dec 7;355(23):2486; author reply 2487-8.

Höcht S, Wachtlin J, Bechrakis NE, Schäfer C, Heufelder J, Cordini D, Kluge H, Foerster M, Hinkelbein W.
Proton or photon irradiation for hemangiomas of the choroid? A retrospective comparison.
Int J Radiat Oncol Biol Phys. 2006 Oct 1;66(2):345-51.

Marnitz S, Cordini D, Bendl R, Lemke AJ, Heufelder J, Simiantonakis I, Kluge H, Bechrakis NE, Foerster MH, Hinkelbein W.
Proton therapy of uveal melanomas: intercomparison of MRI-based and conventional treatment planning.
Strahlenther Onkol. 2006 Jul;182(7):395-9.

Höcht S.
Editorial comment
J Urology 2006; 175(5): 1690

Höcht S, Hinkelbein W, Marnitz S.
The role of radiotherapy in the management of malignant melanoma.
Front Radiat Ther Oncol 2006; 39: 140-148

Kielbassa AM, Hinkelbein W, Hellwig E, Meyer-Lückel H.
Radiation-related damage to dentition.
Lancet Oncol. 2006 Apr;7(4):326-35. Review.

Marnitz S, Köhler C, Schneider A, Seiler F, Hinkelbein W.
Interindividual variability of lymph drainages in patients with cervical cancer. Implication on irradiation planning.
Strahlenther Onkol. 2006 Feb;182(2):80-5.

Wegener J, Zaute F, Höcht S, Köhler B, Bienefeld K.
Suppression of worker fertility in the honey bee (Apis mellifera) by treatment with X-rays.
J Apicult Res. 2006; 45:27-32

Marnitz S, Köhler C, Füller J, Hinkelbein W, Schneider A.
Uterus necrosis after radiochemotherapy in two patients with advanced cervical cancer.
Strahlenther Onkol. 2006 Jan;182(1):45-51.

Marnitz S, Hoecht S, Hinkelbein W.
The role of radiotherapy in the management of malignant melanoma.
Front Radiat Ther Oncol. 2006;39:140-8. Review. No abstract available.

To top

2005

Höcht S, Stark R, Seiler F, Heufelder J, Bechrakis NE, Cordini D, Marnitz S, Kluge H, Foerster MH, Hinkelbein W.
Proton or stereotactic photon irradiation for posterior uveal melanoma? A planning intercomparison.
Strahlenther Onkol. 2005 Dec;181(12):783-8.

Marnitz S, Köhler C, Roth C, Füller J, Hinkelbein W, Schneider A.
Is there a benefit of pretreatment laparoscopic transperitoneal surgical staging in patients with advanced cervical cancer?
Gynecol Oncol. 2005 Dec;99(3):536-44. Epub 2005 Aug 29.

Loddenkemper C, Hoecht S, Anagnostopoulos I, Heine B, Stoltenburg-Didinger G, Stein H.
A 62-year-old man with chronic pyothorax.
Brain Pathol. 2005 Oct;15(4):371-3.

Höcht S, Hinkelbein W.
Postoperative radiotherapy for prostate cancer.
Lancet. 2005 Aug 13-19;366(9485):524-5.

Kaiser S, Höcht S, Lindermann K, Forterre F, Brunnberg L.
Low dose radiotherapy of canineoseoarthitis
Kleintierpraxis 2005;50:9-16

Klemm P, Marnitz S, Köhler C, Braig U, Schneider A.
Clinical implication of laparoscopic pelvic lymphadenectomy in patients with vulvar cancer and positive groin nodes.
Gynecol Oncol. 2005 Oct;99(1):101-5.

Hoecht S, Hinkelbein W.
Treatment of localized lymphoma.
N Engl J Med. 2005 Jun 9;352(23):2449-51; author reply 2449-51.

Gross MW, Altscher R, Brandtner M, Haeusser-Mischlich H, Chiricuta IC, Siegmann AD, Engenhart-Cabillic R.
Open-label simultaneous radio-chemotherapy of glioblastoma multiforme with topotecan in adults.
Clin Neurol Neurosurg. 2005 Apr;107(3):207-13.

Bottke D, Wiegel T, Kreusel KM, Höcht S, Hinkelbein W.
Is a diagnostic CT of the brain indicated in patients with choroidal metastases before radiotherapy?
Strahlenther Onkol. 2005 Apr;181(4):251-4.

Deger S, Boehmer D, Roigas J, Schink T, Wernecke KD, Wiegel T, Hinkelbein W, Budach V, Loening SA.
High dose rate (HDR) brachytherapy with conformal radiation therapy for localized prostate cancer.
Eur Urol. 2005 Apr;47(4):441-8.

Burdak-Rothkamm S, Rübe CE, Nguyen TP, Ludwig D, Feldmann K, Wiegel T, Rübe C.
Radiosensitivity of tumor cell lines after pretreatment with the EGFR tyrosine kinase inhibitor ZD1839 (Iressa).
Strahlenther Onkol. 2005 Mar;181(3):197-204.

Budach V, Stuschke M, Budach W, Baumann M, Geismar D, Grabenbauer G, Lammert I, Jahnke K, Stueben G, Herrmann T, Bamberg M, Wust P, Hinkelbein W, Wernecke KD.
Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial.
J Clin Oncol. 2005 Feb 20;23(6):1125-35.

To top

2004

Höcht S, Wiegel T, Siegmann A, Hinkelbein W.
Radiochemotherapy in unresectable pancreatic cancer.
Front Radiat Ther Oncol. 2004;38:87-93.

Höcht S, Hammad R, Thiel H, Wiegel T, Siegmann A, Willner J, Wust P, Herrmann T, Eble M, Carstens D, Flentje M, Neumann P, Hinkelbein W.
A multicenter analysis of 123 patients with recurrent rectal cancer within the pelvis.
Front Radiat Ther Oncol. 2004;38:41-51.

Bottke D, Wiegel T,, Müller M, Höcht S, Altwein JE, Miller K, Hinkelbein W.
Strahlentherapie nach radikaler Prostatektomie. Vorgehen bei PSA-Persistenz oder Anstieg ohne histologische Sicherung eines Lokalrezidivs.
Deutsches Ärzteblatt 2004; 101:A2255-2259.

Bottke D, Hammersen S, Höcht S, Hinkelbein W.
Das spinale Kompressionssyndrom: Diagnostik und interdisziplinäre Therapie.
Der Onkologe 2004; 10:345-350.

Schostak M, Wiegel T, Müller M, Hoecht S, Schrader M, Straub B, Bottke D, Hinkelbein W, Miller K.
Shared decision-making--results from an interdisciplinary consulting service for prostate cancer.
World J Urol. 2004 Dec;22(6):441-8.

Höcht S, Bechrakis NE, Nausner M, Kreusel KM, Kluge H, Heese J, Heufelder J, Cordini D, Homeyer H, Fuchs H, Martus P, Foerster MH, Wiegel T, Hinkelbein W.
Proton therapy of uveal melanomas in Berlin. 5 years of experience at the Hahn-Meitner Institute.
Strahlenther Onkol. 2004 Jul;180(7):419-24.

Heufelder J, Cordini D, Fuchs H, Heese J, Homeyer H, Kluge H, Morgenstern H, Höcht S, Nausner M, Bechrakis NE, Hinkelbein W, Foerster MH.
[Five years of proton therapy of eye neoplasms at the Hahn-Meitner Institute, Berlin]
Z Med Phys. 2004;14(1):64-71.

Bechrakis NE, Höcht S, Martus P, Kreusel KM, Heese J, Foerster MH.
[Endoresection following proton beam irradiation of large uveal melanomas]
Ophthalmologe. 2004 Apr;101(4):370-6. German.

Pauschinger M, Spencker S, Schwimmbeck P, Bottke D, Hinkelbein W, Shultheiss HP.
Stellenwert der intrakoronaren Brachytherapie im Zeitalter der beschichteten Stents.
CardioVcasc 2004; 3:40-46. German.

Höcht S, Deppermann KM, Bottke D, Hinkelbein W.
Managementstrategien bei der oberen Einflu?stauung.
Der Onkologe 2004; 10:325-333.

Jaster M, Fuster V, Rosenthal P, Pauschinger M, Tran QV, Janssen D, Hinkelbein W, Schwimmbeck P, Schultheiss HP, Rauch U.
Catheter based intracoronary brachytherapy leads to increased platelet activation.
Heart. 2004 Feb;90(2):160-4.

Höcht S, Wiegel T, Siegmann A, Hinkelbein W.
Radiochemotherapy in unresectable pancreatic cancer.
Front Radiat Ther Oncol 2004; 38:87-93.

Höcht S, Hammad R, Thiel HJ, Wiegel T, Siegmann A, Willner J, Wust P, Herrmann T, Eble M, Flentje M, Carstens D, Bottke D, Neumann P, Hinkelbein W.
Recurrent rectal cancer within the pelvis. A multicenter analysis of 123 patients and recommendations for adjuvant radiotherapy.
Strahlenther Onkol. 2004 Jan;180(1):15-20.

Höcht S, Hammad R, Thiel HJ, Wiegel T, Siegmann A, Willner J, Wust P, Herrmann T, Eble M, Carstens D, Flentje M, Neumann P, Hinkelbein W.
A multicenter analysis of 123 patients with recurrent rectal cancer within the pelvis.
Front Radiat Ther Oncol 2004; 38:41-51.

Höcht S, Mann B, Germer CT, Hammad R, Siegmann A, Wiegel T, Buhr HJ, Hinkelbein W.
Pelvic sidewall involvement in recurrent rectal cancer.
Int J Colorectal Dis. 2004 Mar;19(2):108-13.

Jaster M, Fuster V, Rosenthal P, Pauschinger M, Tran QV, Janssen D, Hinkelbein W, Schwimmbeck P, Schultheiss HP, Rauch U.
Catheter based intracoronary brachytherapy leads to increased platelet activation.
Heart. 2004 Feb;90(2):160-4.

To top

2003

Bottke D, Wiegel T, Höcht S, Müller M, Schostak M, Hinkelbein W.
Salvage radiotherapy in patients with persisting prostate-specific antigen after radical prostatectomy for prostate cancer.
Oncology. 2003;65 Suppl 1:18-23.

Kreusel KM, Bechrakis n, Wiegel T, Emmerlich T, Foerster MH.
Clinical characteristics of choroidal metastasis.
Ophthalmologe 2003; 100(8):618-622

Mühr-Wilkenshoff F, Hinkelbein W, Ohnesorge I, Wolf KJ, Riecken EO, Zeitz M, Scherübl H.
A pilot study of irinotecan (CPT-11) as single-agent therapy in patients with locally advanced or metastatic esophageal carcinoma.
Int J Colorectal Dis. 2003 Jul;18(4):330-4.

Höcht S.
Evaluating toxicity in neoadjuvant radio-chemotherapy of rectal cancer.
Int J Colorectal Dis. 2003 Nov;18(6):500-2.

Rosenthal P, Weber W, Förster A, Orth O, Köhler B, Seiler F.
Calibration and validation of a quality assurance system for 90Sr/90Y radiation source trains.
Phys Med Biol. 2003 Mar 7;48(5):573-85.

To top